Analysis of cytokines in the peritoneal fluid of endometriosis patients as a function of the menstrual cycle stage using the Bio-Plex® platform

Archives of Physiology and Biochemistry

Volumn 118, Issue 4, 2012, Pages 210-218

  Bersinger, Nick A ^a   Dechaud, Hervé ^b   McKinnon, Brett ^a   Mueller, Michael D ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIV MONTPELLIER   (France)

Author keywords

Cytokines; Endometriosis; Menstrual cycle; Peritoneal fluid

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ADULT; ARTICLE; ASCITES FLUID; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSTRUMENTATION; MENSTRUAL CYCLE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY;

ADULT; ASCITIC FLUID; BIOLOGICAL MARKERS; CYTOKINES; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MENSTRUAL CYCLE;

EID: 84865449934     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.687003     Document Type: Article

References (36)

1. Akoum A, Lemay A, McColl S, Turcot L, Maheux R. (1996). Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril 66:17-23.
2. Arici A, Tazuke SI, Attar E, Kliman HJ, Olive DL. (1996). Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 2:40-45.
3. ASRM. (1997). The revised American Society for Reproductive Medicine classification of endometriosis 1996. Fertil Steril 67:817-21.
4. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR. (2002). Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17:426-31.
5. Bersinger NA, McKinnon B, Kuhn A, Santi A, Mueller MD. (2009). Pain symptoms and peritoneal fluid cytokine and marker concentrations in women with and without endometriosis. J Endometriosis 1:137-49.
6. Calhaz-Jorge C, Costa AP, Santos MC, Palma-Carlos ML. (2003). Peritoneal fluid concentrations of interleukin-8 in patients with endometriosis depend on the severity of the disorder and are higher in the luteal phase. Hum Reprod 18:593-7.
7. Codorean E, Nichita C, Albulescu L, Raducan E, Popescu I, Lonita AC, Albulescu R. (2010). Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro. Roum Arch Microbiol Immunol 69:13-19.
8. Donnez J, Nisolle M, Casanas-Roux F, Bassil S, Anaf V. (1995). Rectovaginal septum, endometriosis or adenomyosis: laparoscopic management in a series of 231 patients. Hum Reprod 10:630-35.
9. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. (1998). Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13:1686-90.
10. Earley MC, Vogt RF, Shapiro HM, Mandy FF, Kellar KL, Bellisario R, Pass KA, Marti GE, Stewart CC, Hannon WH. (2002). Multianalyte microsphere assays (workshop report). Cytometry 50:239-42.
11. Fakih H, Baggett B, Holtz G, Tsang KY, Lee JC, Williamson HO. (1987). Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 47:213-17.
12. Gupta S, Agarwal A, Sekhon L, Krajcir N, Cocuzza M, Falcone T. (2006). Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. Minerva Ginecol 58:527-51.
13. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. (1984). Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 64:151-4.
14. Harada T, Enatsu A, Mitsunari M, Nagano Y, Ito M, Tsudo T, Taniguchi F, Iwabe T, Tanikawa M, Terakawa N. (1999). Role of cytokines in progression of endometriosis. Gynecol Obstet Invest 47 (Suppl. 1):34-40.
15. Hornung D, Dohrn K, Sotlar K, Greb RR, Wallwiener D, Kiesel L, Taylor RN. (2000). Localization in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis. J Clin Endocrinol Metab 85:2604-8.
16. Khan IH, Krishnan VV, Ziman M, Janatpour K, Wun T, Luciw PA, Tuscano J. (2009). Comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry 76B:159-68.
17. Khorram O, Taylor R, Ryan I, Schall T, Landers D. (1993). Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 169: 1545-9.
18. Kruitwagen RF, Poels LG, Willemsen WN, de Ronde IJ, Jap PH, Rolland R. (1991). Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil Steril 55:297-303.
19. Lebovic DI, Mueller MD, Taylor RN. (2001). Immunobiology of endometriosis (Review). Fertil Steril 75:1-10.
20. Mier-Cabrera J, Jiménez-Zamudio L, García-Latorre E, Cruz-Orozco O, Hernández-Guerrero C. (2011). Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stressassociated characteristics in women with minimal and mild endometriosis. Brit J Obstet Gynaecol 118:6-16.
21. Mueller MD, Mazzucchelli L, Buri C, Lebovic DI, Dreher E, Taylor RN. (2003). Epithelial neutrophil-activating peptide 78 concentrations are elevated in the peritoneal fluid of women with endometriosis. Fertil Steril 79 (Suppl. 1):815-20.
22. Nishida M, Nasu K, Narahara H. (2011). Role of chemokines in the pathogenesis of endometriosis. Front Biosci (Schol Edn) 3:1196-204.
23. Nisolle M, Casanas B, Anaf V, Mine J, Donnez J. (1993). Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril 59:681-4.
24. Nisolle M, Donnez J. (1997). Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 68:585-96.
25. Pang S, Smith J, Onley D, Reeve J, Walker M, Foy C. (2005). A comparability study of the emerging protein array platforms with established ELISA procedures. Journal Immunol Meth 302:1-12.
26. Parazzini F, Cipriani S, Moroni S, Crosignani PG (Gruppo Italiano per lo studio dell'endometriosi). (2001). Relationship between stage, site and morphological characteristics of pelvic endometriosis and pain. Hum Reprod 16:2668-71.
27. Punnonen J, Teisala K, Ranta H, Bennett B, Punnonen R. (1996). Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 174:1522-6.
28. Rapkin A, Morgan M, Bonpane C, Martinez O. (2000). Peritoneal fluid interleukin-6 in women with chronic pelvic pain. Fertil Steril 74:325-8.
29. Ryan I, Tseng J, Schriock E, Khorram O, Landers D, Taylor R. (1995). Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 63: 929-32.
30. Sampson JA. (1927). Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 3:93-110.
31. Siristatidis C, Nissotakis C, Chrelias C, Iacovidou H, Salamalekis E. (2006). Immunological factors and their role in the genesis and development of endometriosis. J Obstet Gynaecol Res 32:162-70.
32. Taylor RN, Lebovic DI, Mueller MD. (2002). Angiogenic factors in endometriosis. Ann NY Acad Sci 955:89-100.
33. Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG. (2007). Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod 22:266-71.
34. Vigano P, Pardi R, Magri B, Busacca M, Di Blasio AM, Vignali M. (1994). Expression of intercellular adhesion molecule-1 (ICAM-1) on cultured human endometrial stromal cells and its role in the interaction with natural killers. Am J Reprod Immunol 32:139-45.
35. Witz CA, Monotoya IA, Schenken RS. (1999). Whole explants of peritoneum and endometrium: a novel model of the early endometriosis lesion. Fertil Steril 71:56-60.
36. Yoshino O, Osuga Y, Koga K, Hirota Y, Tsutsumi O, Yano T, et al. (2003). Concentrations of interferon-γ-induced protein-10 (IP-10), an antiangiogenic substance, are decreased in peritoneal fluid of women with advanced endometriosis. Am J Reprod Immunol 50:60-65.